首页 | 本学科首页   官方微博 | 高级检索  
     

民营中小医药企业新药研发模式探析
引用本文:王勇,廖淑雯,吴晓明. 民营中小医药企业新药研发模式探析[J]. 中国现代应用药学, 2011, 28(3): 276-280
作者姓名:王勇  廖淑雯  吴晓明
作者单位:中国药科大学国际医药商学院,南京 210009;中国药科大学国际医药商学院,南京 210009;中国药科大学国际医药商学院,南京 210009
摘    要:目的探讨现阶段适合我国民营中小医药企业发展的新药研发战略模式。方法分析我国医药行业和民营中小医药企业研发现状,研究现有的3种研发模式——开拓性创新、模仿创新和完全仿制各自的优劣及所适合的企业类型。结果通过SWOT分析发现,民营中小医药企业大多具有行为优势,但不具备资源优势,资金、技术以及人力等资源投入都不足。结论根据民营中小医药企业的综合实力,现阶段选择模仿创新战略更具可行性,可更有效发挥有限资源的使用效率、减小风险;实施过程中要注意选题方向、立项调研评估、专利战略等问题。

关 键 词:研发  模仿创新  开拓性创新
收稿时间:2010-10-09

Discussion of the R&D Models for Chinese Private Small and Medium Pharmaceutical Enterprises
WANG Yong,LIAO Shuwen and WU Xiaoming. Discussion of the R&D Models for Chinese Private Small and Medium Pharmaceutical Enterprises[J]. The Chinese Journal of Modern Applied Pharmacy, 2011, 28(3): 276-280
Authors:WANG Yong  LIAO Shuwen  WU Xiaoming
Affiliation:International Business School of China Pharmaceutical University, Nanjing 210009, China;International Business School of China Pharmaceutical University, Nanjing 210009, China;International Business School of China Pharmaceutical University, Nanjing 210009, China
Abstract:OBJECTIVE To study the R&D models fit for the Chinese private small and medium pharmaceutical enterprises nowadays. METHODS Trough studying the current R&D situation of the Chinese pharmaceutical industry and private small and medium enterprises, this thesis introduced three R&D models, and analyzed their characteristics and applicability for what kinds of enterprise respectively. RESULTS The SWOT analysis showed that most of the private small and medium enterprises had behavioral advantages, but no resources advantages. Their capital, technology and human resource were insufficient. CONCLUSION According to the overall strength of private small and medium enterprises, this thesis suggests that simulating innovation strategy model would be more feasible at this stage. It can enhance the efficiency of limited resources and reduce risk. The enterprises should pay attention to the matters of research project choosing, project evaluation, patent strategy, and etc..
Keywords:research and development   simulating innovation   breakthrough innovation
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号